Exelixis Inc (EXEL)
34.83
+0.18
(+0.52%)
USD |
NASDAQ |
Nov 21, 16:00
34.82
0.00 (0.00%)
After-Hours: 20:00
Exelixis Price to Book Value: 4.371 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 4.349 |
| November 19, 2024 | 4.319 |
| November 18, 2024 | 4.332 |
| November 15, 2024 | 4.324 |
| November 14, 2024 | 4.399 |
| November 13, 2024 | 4.417 |
| November 12, 2024 | 4.499 |
| November 11, 2024 | 4.542 |
| November 08, 2024 | 4.550 |
| November 07, 2024 | 4.493 |
| November 06, 2024 | 4.457 |
| November 05, 2024 | 4.364 |
| November 04, 2024 | 4.304 |
| November 01, 2024 | 4.282 |
| October 31, 2024 | 4.167 |
| October 30, 2024 | 4.071 |
| October 29, 2024 | 3.606 |
| October 28, 2024 | 3.577 |
| October 25, 2024 | 3.498 |
| October 24, 2024 | 3.528 |
| October 23, 2024 | 3.554 |
| October 22, 2024 | 3.618 |
| October 21, 2024 | 3.597 |
| October 18, 2024 | 3.630 |
| October 17, 2024 | 3.650 |
| Date | Value |
|---|---|
| October 16, 2024 | 3.686 |
| October 15, 2024 | 3.579 |
| October 14, 2024 | 3.296 |
| October 11, 2024 | 3.294 |
| October 10, 2024 | 3.229 |
| October 09, 2024 | 3.194 |
| October 08, 2024 | 3.189 |
| October 07, 2024 | 3.304 |
| October 04, 2024 | 3.348 |
| October 03, 2024 | 3.296 |
| October 02, 2024 | 3.328 |
| October 01, 2024 | 3.303 |
| September 30, 2024 | 3.259 |
| September 27, 2024 | 3.493 |
| September 26, 2024 | 3.531 |
| September 25, 2024 | 3.507 |
| September 24, 2024 | 3.536 |
| September 23, 2024 | 3.547 |
| September 20, 2024 | 3.555 |
| September 19, 2024 | 3.610 |
| September 18, 2024 | 3.609 |
| September 17, 2024 | 3.714 |
| September 16, 2024 | 3.697 |
| September 13, 2024 | 3.561 |
| September 12, 2024 | 3.540 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.937
Minimum
Oct 10 2022
4.811
Maximum
May 11 2020
3.088
Average
3.016
Median
Price to Book Value Benchmarks
| Merck & Co Inc | 5.676 |
| ADMA Biologics Inc | 21.71 |
| Vericel Corp | 10.87 |
| Catalyst Pharmaceuticals Inc | 3.812 |
| Inovio Pharmaceuticals Inc | 1.443 |
Price to Book Value Related Metrics
| PE Ratio | 22.32 |
| PS Ratio | 5.036 |
| PEG Ratio | 0.0495 |
| Price to Free Cash Flow | 25.89 |
| Price | 34.83 |
| Earnings Yield | 4.48% |
| Market Cap | 9.947B |
| PEGY Ratio | 0.0495 |
| Operating PE Ratio | 17.23 |
| Normalized PE Ratio | 19.59 |